A roadside study in 2015 0. ABSTRACT A survey was conducted during 2015 to monitor psychoactive substance use in a sample of drivers in Spanish roads and cities. Traffic police officers recruited drivers at sites carefully chosen to achieve representativeness of the driver population. A brief questionnaire included the date, time, and personal and driving patterns data. Alcohol use was ascertained through ethanol breath test at the roadside and considered positive if concentrations >0.05mg alcohol/L were detected. Four drug classes were assessed onsite through an oral fluid screening test that, if positive, was confirmed through a second oral fluid sample at a reference laboratory. Laboratory confirmation analyses screened for 26 psychoactive substances. To evaluate the association between drug findings and age, sex, road type (urban/interurban), and period of the week (weekdays, weeknights, weekend days, weekend nights), logistic regression analyses were done (overall, and separately for alcohol, cannabis and cocaine).
INTRODUCTION
Road traffic accidents constitute an important health burden worldwide. This problem was highlighted by a report from the WHO in 2004. It is estimated to be increasing, particularly in low-income countries [1] . To overcome this burden, in Europe a target of significantly reducing road traffic fatalities (50% fewer deaths on the road in the period 2002-2010) was set [2] . In order to attain it, various initiatives have been implemented. As one of the major factors affecting driving performance is the consumption of psychoactive substances, in the EU there was a need to assess the prevalence of driving under the influence of alcohol and other psychoactive drugs and medicines. The EU funded DRUID project (Driving Under the Influence of Drugs, Alcohol and Medicines) was initiated in 2006 [3] , and included the use of roadside drug testing equipment by the police. Spain was a partner in the DRUID project and a survey among drivers was performed in 2008 [4] .
To continue monitoring the situation and in order to assess actions taken, a new survey was conducted in 2013 [5] and repeated in 2015, within the Spanish Research Plan on Road Safety and Mobility 2013-2016 [6] ; the so-called "Estudio sobre la prevalencia del consumo de sustancias psicoactivas en conductores de
vehiculos de España-EDAP"[Prevalence study of psychoactive substances use among Spanish drivers].
From the law enforcement point of view, it would be necessary to consider whether roadside screen tests for substances other than alcohol, have an adequate validity. On-site tests for oral fluid are considered an effective and non-invasive method to detect drug-use, but some problems of sensitivity for substances still remain [7, 8] The aim of the present study was to assess the prevalence of alcohol and illicit drugs use, and selected psychoactive substances beyond those tested at the roadside, through analyses of oral fluid and breathtests in a representative nationwide sample of the general population of drivers in Spain. A secondary aim was to assess sensitivity and specificity of the roadside device used (Dräger DrugTest®).
METHODS
An observational study among drivers of motor vehicles (bicycles and vehicles over 3,500 kg were excluded) on public roads in Spain was conducted in 2015. To obtain a representative sample nationwide, a multistage method was applied to select 128 police control sites. In the first stage, the country was divided in four Areas (''Cantábrica'', ''Norte'', ''Mediterránea'', and ''Sur''). In a second step, within each of these four areas, four population stratums according to cities' population sizes (less than 10,000 inhabitants, 10,000-99,999 inhabitants, 100,000-499,999, and 500,000 inhabitants and over) were defined, in each of which two sectors, one urban the other interurban, were considered; in each combination of stratum and sector, four zones were randomly selected, resulting in a total of 32 zones. The third step involved choosing four roadside check points in each zone according to predefined selection criteria for each sector (urban/interurban), allowing the selection of 128 roadside check points, or police control sites. Finally, in each one of them, the number of police control actions and the quota of drivers to be recruited per action was determined based on the population size. Control actions were planned in four spring (interurban) and four autumn (urban) weeks. Four periods were selected within those weeks, considering different days of the week and hours of the day (a) Monday-Friday from 7:00 to 23:59 h (weekdays); (b) Tuesday-Friday from 0:00 to 6:59 h (weeknights); (c) Saturday, Sunday and holidays from 7:00 to 23:59 h (weekend days); (d) Saturday, Sunday, Monday and holidays from 0:00 to 6:59 h (weekend nights).
Driver recruitment and data collection
Drivers of either Spanish or foreign nationality were recruited by a traffic police officer at the police control site when space was available for a vehicle to be stopped at the site. According to Spanish legislation, participation in roadside police controls is mandatory; thus participation rate was 100%. After informing the driver about the aim of the control and samples needed, oral fluid samples were obtained and then drivers were submitted to an alcohol breath test. Two samples of oral fluid (approximately 1 mL each) were taken using specific devices (Quantisal®, Alere Toxicology Plc, UK); one of them screened at roadside for opiates, amphetamines, cocaine and metabolites, and cannabinoids, using the Dräger DrugTest® 5000 (Dräger Safety AG & Co, Lübeck, Germany) [9] . If a positive result was obtained for at least one substance, the second sample was sent for laboratory confirmation, in a special container at a temperature between 2 
Toxicological aspects
At the roadside, the Dräger DrugTest device was used for drug screening using the following cut-off The quantitative drug confirmation test in oral fluid for 26 substances (Table 1 ) was performed after a solid phase extraction procedure. Extracts were analyzed by liquid chromatography coupled to tandem mass spectrometry ( UHPLC-MS/MS). The concentration was calculated in neat oral fluid by using the average dilution factor specified by the manufacturer (1/4). All oral fluid samples were analyzed in the same laboratory (accredited following the ISO17025 by the national accreditation body -ENAC [Entidad Nacional de Acreditación (Spanish National Accreditation Body)]-for this kind of analyses).
Assessment of agreement between roadside (on-site drug screening test) and laboratory tests was only possible among drivers for whom a second oral fluid sample was sent for laboratory confirmation, meaning they had at least one oral fluid positive result at roadside. For these drivers, sensitivity and specificity was calculated overall and for each of the four drug classes screened at roadside: Cannabis, Opioids, Cocaine and Amphetamines, allowing a partial appraisal of drug use screening at the roadside. Sensitivity was defined as the ability of the test to identify correctly those who have the disease; while specificity as the ability of the test to identify correctly those who do not have the disease.
Data analysis
An anonymized database was built including questionnaire data as well as laboratory confirmation results.
All the variables in the database were examined for accuracy of data entry and missing values. Ketamine and Z-Pharmaceuticals (zopiclone, zolpidem). When only pharmaceutical drugs were detected in a sample the result was considered negative for alcohol or illegal substances. Comparisons between groups were carried out using χ 2 and Fisher's exact tests for categorical variables and Student's t-test and analyses of variance (ANOVA) for continuous variables. Logistic regression analyses were used to evaluate the association between positive drug findings and age, sex (male/female), road type (urban/interurban), and period of the week (weekdays, weeknights, weekend days, weekend nights) both overall and separately for alcohol, cannabis and cocaine. Age and gender were included in the regression model even if not significant. Significance level was set at p ≤ 0.05 with two-tailed tests. The statistical package SPSS 22.0 was used for all analyses.
RESULTS

Characteristics of drivers involved in the study
A total of 2744 drivers were included in the study, 77.8% were males. Their mean age was 37.5 years [standard deviation (SD) 12.0; range . Most of the participants were Spanish (88.7%) and drove a car (87.7%). Sex differences were observed in nationality, probably related to the fact that no Moroccan women were included; also the great majority of females drove a private car and females were more likely to be stopped on urban roads (Table 2) . 
Prevalence of positive cases and their characteristics
The roadside ethanol breath test gave positive results for 72 drivers (2.6%). Roadside screening tests detected a total of 353 drivers (12.9%) with a positive result for at least one of the tested substances (including alcohol). Of these, 7.8% were positive for cannabis, 3.5% for cocaine, 1.5% for amphetamine-like stimulants/designer drugs, and 0.5% for opiates/methadone.
Considering alcohol at roadside and laboratory confirmation results for the rest of substances, after excluding those subjects (n=5) with only a pharmaceutical drug, 11.6% of the drivers were positive for at least one of the substances assessed (Figure 1) . Overall 7.7% tested positive for only one substance, 3.1% were positive for a combination of substances (alcohol not included), and only 0.8% gave positive results for alcohol and another substance (Table 3) . Cannabis, cocaine and alcohol (separately) were the substances that were most frequently found (7.5%, 4.7% and 2.6%, respectively). Positive cases for amphetamine-like stimulants/designer drugs were also common (1.3%), followed by benzodiazepines, opiates/methadone (90% of which were positive for 6-monoacetylmorphine) and ketamine (no Z-drugs were detected), all of them with rates lower than 1%.
Prevalence of positive cases for any substance (whether alone or combined with alcohol) was higher in males (13.4%) than in females (5.1%). When considering different substances separately, differences by gender were observed for alcohol, cannabis and cocaine, being more likely in males than in females (Table 3) .
Also, the likelihood of finding a driver positive for some substance decreased with age (p < 0.0001) ( Table 4 ).
The highest prevalence of positive results for cannabis (15.2%) was found in the younger age group (18-24 years), whereas the highest for cocaine (7.4%) was found in the group aged 25 to 34 years. In turn, driving under the influence of any drug was more likely at night (both on weekdays and at weekends) than during daytime (p = 0.001). This pattern was also observed for alcohol (p < 0.0001) and cocaine (p = 0.002).
Regarding the type of road, it was more likely to find drivers positive for both alcohol and other substances in urban settings (p < 0.001). Likewise, when considering different substances separately, alcohol and cannabis were also more frequently observed in urban settings (p < 0.0001 and p = 0.029, respectively). 
3.3.-Sensitivity and specificity.-
The level of agreement overall between the two tests (on-site drug testing vs. confirmatory analysis by LC-MS) for the four analyzed substances was 88.4%. Taking into account all drugs (295 drivers*4 tests), 52 (18%) false positive and 85 (29%) false negative results were detected.
The best agreement with Dräger DrugTest® findings and laboratory confirmation was found for cannabis (sensitivity of 90%, and specificity of 77%), followed by cocaine (sensitivity of 68% and specificity of 96%).
The specificity figure for cannabis means that some of the positive results for cannabis on-site were not confirmed by laboratory tests (23%), whereas the sensitivity for cocaine means that laboratory tests gave positive results which screening tests had not detected previously (false negatives) (32%)( Table 6 ). The Dräger DrugTest® on-site device provided the lowest sensitivity (47%) and the highest specificity (97%) for detection of Opiates/Methadone, which were the substances less frequently detected. 
DISCUSSION
This roadside study with a representative nationwide sample of the general population of drivers in Spain found that a significant percentage of drivers (11.6%) had used substances that may affect driving performance. In four percent (4%) of drivers two or more substances were detected. The most common substances were cannabis, cocaine and alcohol, in that order. Males were more likely than females to use any substance overall, as well as alcohol. Drivers tested in urban roads were more likely to use any substance, and alcohol. The only factor associated with positive tests for cannabis was age, whereas for cocaine, drivers tested at weeknights and weekend nights were more likely to be positive. Driving at night was also associated with positive results for alcohol. Agreement between roadside screening results and laboratory confirmation for subjects with at least one positive result at roadside was higher for cannabis and cocaine.
As pointed out previously, the present study represents a continuation in When comparing the prevalence of psychoactive substances among drivers with that of the general population in Spain, we need to take into account two factors: first, reports from surveys are selfreported data, and second, the time periods considered were different. EDAP provided objective prevalence at a very specific time point linked to driving, while the biannual national survey EDADES (Encuesta sobre Alcohol y Drogas en España) [11] , including a broad sample of the Spanish non- among the highest in the study [4] .
Although oral fluid drug concentrations should parallel those in blood, recent studies in populations of drivers with low prevalence of drug consumption show that oral fluid samples do not accurately reflect blood concentrations [13] . Regarding validity of screen tests, we are able to assess sensitivity and specificity for substances tested by the device Dräger DrugTest®, but only among persons who were positive for at least one substance. In contrast to some studies indicating that further improvement is needed to enhance the sensitivity for detection of THC in oral fluid [14] , in the present study, the Dräger DrugTest R 5000 provided the highest sensitivity for detection of cannabis (90%), with a lower figure for specificity (77%). However, in the present study the percentage of false positives in cocaine was 4%
(specificity of 96%, with a sensitivity of 68%), data that contrasts to the 11% found in another study [14] . A low sensitivity of the roadside screen test may be related to the fact that screening cut-off concentrations are higher than those from the certified laboratory, and this may explain cocaine results, especially the false negatives (32%). Conversely, the low specificity of cannabis screen test is more difficult to elucidate, though it may be related to its high sensitivity. This is relevant, as similarly to the general population, cocaine and cannabis are the most common illegal substances among drivers. Globally the discussion on sensitivity and specificity of the testing device in our report is biased by the fact that only those samples testing positive for a given substance were retested for the rest of the panel in the confirmatory laboratory. Therefore our estimates are based on samples testing positive for drugs and do not refer to a population of samples with mixed positive and negative oral fluids. Nevertheless this early discussion does not preclude the debate on the reliability of these testing devices. The performance of the analytical device for cocaine was not particularly good.
Concerning psychoactive non-illicit drugs, it was not possible to verify if they were used under prescription. This could be of relevance as non-prescribed use of psychoactive prescription drugs is common in subjects suspected of drug-impaired driving [15, 16] . Quantification of these other drugs allow
for an overall picture of drug use among drivers, beyond the most common illegal substances.
Limitations
Some limitations need to be mentioned. First of all we need to point out difficulties in fieldwork, affecting both recruitment and organizational aspects (e.g.: one big city in the Mediterranean area could not be included; a few questionnaires (9) from positive laboratory samples could not be retrieved, nor were confirmatory samples obtained for 6 positive questionnaires). Furthermore, data collected didn't allow weighting for traffic intensity using the same procedure employed in previous editions, and consequently only roadside screening results have been weighted with traffic intensity at each check point, to be able to make a comparison. Also, traffic police officers recruited drivers according to space availability at police check points, but we cannot discard that riskier drivers had been selected. Furthermore, the overall performance of the Dräger DrugTest® as a screening tool needs to be taken into account to adequately appraise the situation. Additionally, contrary to other countries [17, 18] , in this study cut-off concentrations were those provided by the testing device in the absence of Spanish legislation defining safety margins for psychoactive drugs.
Drivers in Spain display a pattern of psychoactive substance use similar to that observed in the general population of adults, except for the case of alcohol which is clearly lower. In fact, alcohol use while driving seems to have diminished over the last decade, probably in response to strong prevention strategies. The dangers related to the use of other substances while driving is not yet well recognized by Spanish drivers.
Roadside tests for psychoactive substances need improvement if they are to constitute an adequate means for enforcing effective vigilance.
